Dermatology · Hallandale Beach, FL
NPI
1821248022
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1830 S Ocean Dr, #3111
Hallandale Beach, FL, 33009
Phone (305) 812-6012
Groups this clinician bills Medicare through
Medicare paid, 2024
$434K
4,639 services
Medicare patients, 2024
892
Average age 78
Drug cost, 2024
$771K
4,858 prescriptions
Company payments, 2025
$47K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank A Don was code 17003 (destruction skin lesion), 1,653 times for 277 patients. In total Frank A Don billed 4,639 services in 100 codes, and Medicare paid $434K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,653 | 277 | $4.92 | $8,137 |
| 17000 Destruction Skin Lesion | Office | 451 | 368 | $37.10 | $17K |
| 99213 Office E&M - Established | Office | 335 | 284 | $63.44 | $21K |
| 17110 Destruction Skin Lesion | Office | 244 | 219 | $84.89 | $21K |
| 11102 Skin Biopsy | Office | 223 | 197 | $61.77 | $14K |
| 17311 Mohs Surgery | Office | 195 | 173 | $450.69 | $88K |
| 99214 Office E&M - Established | Office | 177 | 153 | $98.65 | $17K |
| 99348 Home E&M - New and Established | Office | 138 | 91 | $54.50 | $7,521 |
| 17312 Mohs Surgery | Office | 133 | 94 | $341.03 | $45K |
| 11103 Skin Biopsy | Office | 85 | 62 | $40.54 | $3,446 |
| 13121 Wound Repair - All Levels | Office | 79 | 73 | $222.95 | $18K |
| 13132 Wound Repair - All Levels | Office | 78 | 73 | $198.45 | $15K |
| 99203 Office E&M - New | Office | 62 | 62 | $70.00 | $4,340 |
| 17313 Mohs Surgery | Office | 53 | 49 | $456.55 | $24K |
| 99347 Home E&M - New and Established | Office | 53 | 41 | $37.07 | $1,965 |
By year: 2022 $213K for 1,768 services; 2023 $283K for 2,833 services; 2024 $434K for 4,639 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank A Don prescribed most often to Medicare patients was Mupirocin, with 834 prescriptions and refills. In total Frank A Don wrote 4,858 Medicare prescriptions that cost $771K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 834 | 835 | 587 | $4,990 |
| Clobetasol Propionate Generic | 687 | 700 | 275 | $62K |
| Doxycycline Hyclate Generic | 586 | 590 | 480 | $6,676 |
| Ketoconazole Generic | 464 | 500 | 217 | $4,982 |
| Triamcinolone Acetonide Generic | 379 | 381 | 220 | $4,562 |
| Ammonium Lactate Generic | 253 | 267 | 130 | $4,457 |
| Hydrocortisone Generic | 145 | 157 | 95 | $2,236 |
| Ciclopirox Generic | 129 | 129 | 65 | $1,787 |
| Fluocinolone Acetonide Generic | 104 | 104 | 49 | $12K |
| Terbinafine Hcl Generic | 103 | 103 | 41 | $817 |
| Hydroxyzine Hcl Generic | 94 | 94 | 38 | $576 |
| Clindamycin Phosphate Generic | 86 | 86 | 39 | $4,528 |
| Ssd Silver Sulfadiazine | 79 | 83 | 47 | $1,091 |
| Minoxidil Generic | 75 | 111 | 25 | $67.25 |
| Metronidazole Generic | 63 | 68 | 33 | $2,610 |
Brand drugs: 213 claims; generic drugs: 4,645 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank A Don $47K ($47K in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 54 | $25K |
| Genzyme Corporation SNY | 13 | $18K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $1,036 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $393 |
| Organogenesis Inc. ORGO | 4 | $275 |
| LEO Pharma Inc. | 9 | $237 |
| Galderma Laboratories, L.P. GALD.SW | 6 | $228 |
| Amgen Inc. AMGN | 3 | $186 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $185 |
| UCB, Inc. UCB.BR | 8 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.